{
    "2018-07-13": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Announces Collaborations with Calico and Calibr",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "collaborations",
                        "Calico",
                        "Calibr"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharma",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVieâ€™s Supplemental New Drug Application for Venetoclax",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "drug application",
                        "Venetoclax"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharma",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "5 Big Pharma Stocks Investors Love Right Now",
                "features": {
                    "keywords": [
                        "big pharma",
                        "investors",
                        "love"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharma"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "2 Overlooked Biotech Stocks to Buy Now",
                "features": {
                    "keywords": [
                        "overlooked",
                        "biotech",
                        "stocks",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Will J&J's (JNJ) Pharma Segment Strength Drive Q2 Earnings?",
                "features": {
                    "keywords": [
                        "J&J",
                        "pharma segment",
                        "Q2 earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit",
                "features": {
                    "keywords": [
                        "PFE",
                        "split",
                        "J&J",
                        "talc lawsuit",
                        "$4.7B"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}